Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 446

1.

Comparison of Core-Needle Biopsy and Fine-Needle Aspiration for Evaluating Thyroid Incidentalomas Detected by 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: A Propensity Score Analysis.

Suh CH, Choi YJ, Lee JJ, Shim WH, Baek JH, Chung HC, Shong YK, Song DE, Sung TY, Lee JH.

Thyroid. 2017 Sep 15. doi: 10.1089/thy.2017.0192. [Epub ahead of print]

PMID:
28791924
2.

Short and broadband silicon asymmetric Y-junction two-mode (de)multiplexer using fast quasiadiabatic dynamics.

Chung HC, Lee KS, Tseng SY.

Opt Express. 2017 Jun 12;25(12):13626-13634. doi: 10.1364/OE.25.013626.

PMID:
28788905
3.

Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer.

Jeung HC, Rha SY, Shin SJ, Ahn JB, Park KH, Kim TS, Kim JJ, Roh JK, Chung HC.

Oncol Lett. 2017 Aug;14(2):2385-2392. doi: 10.3892/ol.2017.6438. Epub 2017 Jun 21.

4.

A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors.

Mateo J, Ganji G, Lemech C, Burris HA, Han SW, Swales K, Decordova S, DeYoung MP, Smith DA, Kalyana-Sundaram S, Wu J, Motwani M, Kumar R, Tolson JM, Rha SY, Chung HC, Eder JP, Sharma S, Bang YJ, Infante JR, Yan L, de Bono JS, Arkenau HT.

Clin Cancer Res. 2017 Jun 23. doi: 10.1158/1078-0432.CCR-17-0725. [Epub ahead of print]

PMID:
28645941
5.

The prognostic value of volume-based parameters using 18F-FDG PET/CT in gastric cancer according to HER2 status.

Park JS, Lee N, Beom SH, Kim HS, Lee CK, Rha SY, Chung HC, Yun M, Cho A, Jung M.

Gastric Cancer. 2017 Jun 22. doi: 10.1007/s10120-017-0739-0. [Epub ahead of print]

PMID:
28643145
6.

Recombinant Thrombomodulin Exerts Anti-autophagic Action in Endothelial Cells and Provides Anti-atherosclerosis Effect in Apolipoprotein E Deficient Mice.

Chen PS, Wang KC, Chao TH, Chung HC, Tseng SY, Luo CY, Shi GY, Wu HL, Li YH.

Sci Rep. 2017 Jun 12;7(1):3284. doi: 10.1038/s41598-017-03443-z.

7.

Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study.

Chau I, Peck-Radosavljevic M, Borg C, Malfertheiner P, Seitz JF, Park JO, Ryoo BY, Yen CJ, Kudo M, Poon R, Pastorelli D, Blanc JF, Chung HC, Baron AD, Okusaka T, Bowman L, Cui ZL, Girvan AC, Abada PB, Yang L, Zhu AX.

Eur J Cancer. 2017 Aug;81:17-25. doi: 10.1016/j.ejca.2017.05.001. Epub 2017 Jun 4.

PMID:
28591675
8.

Complete Genome Sequences of Porcine Deltacoronavirus Strains DH1/2016 and DH2/2016 Isolated in South Korea.

Chung HC, Nguyen VG, Oh WT, My Le HT, Moon HJ, Lee JH, Kim HK, Park SJ, Park BK.

Genome Announc. 2017 May 4;5(18). pii: e01706-16. doi: 10.1128/genomeA.01706-16.

9.

Modulation of HAT activity by the BRCA2 N372H variation is a novel mechanism of paclitaxel resistance in breast cancer cell lines.

Kwon WS, Rha SY, Jeung HC, Kim TS, Chung HC.

Biochem Pharmacol. 2017 Aug 15;138:163-173. doi: 10.1016/j.bcp.2017.04.015. Epub 2017 Apr 18.

PMID:
28431939
10.

Prevalence and prognostic implications of psychological distress in patients with gastric cancer.

Kim GM, Kim SJ, Song SK, Kim HR, Kang BD, Noh SH, Chung HC, Kim KR, Rha SY.

BMC Cancer. 2017 Apr 20;17(1):283. doi: 10.1186/s12885-017-3260-2.

11.

Oral intake of Boesenbergia pandurata extract improves skin hydration, gloss, and wrinkling: A randomized, double-blind, and placebo-controlled study.

Kim DU, Chung HC, Kim C, Hwang JK.

J Cosmet Dermatol. 2017 Apr 18. doi: 10.1111/jocd.12343. [Epub ahead of print]

PMID:
28421656
12.

Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer.

Kim HS, Lee H, Shin SJ, Beom SH, Jung M, Bae S, Lee EY, Park KH, Choi YY, Son T, Kim HI, Cheong JH, Hyung WJ, Park JC, Shin SK, Lee SK, Lee YC, Koom WS, Lim JS, Chung HC, Noh SH, Rha SY, Kim H, Paik S.

Oncotarget. 2017 Jun 13;8(24):38389-38398. doi: 10.18632/oncotarget.16409.

13.

Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab.

Lee CK, Kim SS, Park S, Kim C, Heo SJ, Lim JS, Kim H, Kim HS, Rha SY, Chung HC, Park S, Jung M.

Oncotarget. 2017 May 9;8(19):31169-31179. doi: 10.18632/oncotarget.16099.

14.

A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors.

Kim GM, Reid T, Shin SJ, Rha SY, Ahn JB, Lee SS, Chung HC.

Invest New Drugs. 2017 Mar 28. doi: 10.1007/s10637-017-0460-1. [Epub ahead of print]

PMID:
28353123
15.

Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study.

Thuss-Patience PC, Shah MA, Ohtsu A, Van Cutsem E, Ajani JA, Castro H, Mansoor W, Chung HC, Bodoky G, Shitara K, Phillips GDL, van der Horst T, Harle-Yge ML, Althaus BL, Kang YK.

Lancet Oncol. 2017 May;18(5):640-653. doi: 10.1016/S1470-2045(17)30111-0. Epub 2017 Mar 23.

PMID:
28343975
16.

Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline.

Sohn BS, Kim SB, Ahn JH, Jung KH, Kim J, Lee KS, Ro J, Im SA, Im YH, Song HS, Park HS, Chung HC.

Asia Pac J Clin Oncol. 2017 Mar 16. doi: 10.1111/ajco.12681. [Epub ahead of print]

PMID:
28303646
17.

Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer.

Park HS, Sohn J, Kim SI, Park S, Park HS, Gho SG, Chung HC, Paik S, Kim GM.

Breast Cancer Res Treat. 2017 Jun;163(2):255-262. doi: 10.1007/s10549-017-4175-y. Epub 2017 Feb 27.

PMID:
28243895
18.

Healthy lifestyle and normal waist circumference are associated with a lower 5-year risk of type 2 diabetes in middle-aged and elderly individuals: Results from the healthy aging longitudinal study in Taiwan (HALST).

Chen CC, Liu K, Hsu CC, Chang HY, Chung HC, Liu JS, Liu YH, Tsai TL, Liaw WJ, Lin IC, Wu HW, Juan CC, Chiu HC, Lee MM, Hsiung CA.

Medicine (Baltimore). 2017 Feb;96(6):e6025. doi: 10.1097/MD.0000000000006025.

19.

Bioaccumulation of lead and non-specific immune responses in white shrimp (Litopenaeus vannamei) to Pb exposure.

Wu YS, Huang SL, Chung HC, Nan FH.

Fish Shellfish Immunol. 2017 Mar;62:116-123. doi: 10.1016/j.fsi.2017.01.011. Epub 2017 Jan 12.

PMID:
28089748
20.

Long-term efficacy and safety of the dual 5-alpha reductase blocker dutasteride on male androgenetic alopecia patients.

Chung HC, Lee S, Lee WS.

J Dermatol. 2016 Dec 18. doi: 10.1111/1346-8138.13710. [Epub ahead of print] No abstract available.

PMID:
27988928

Supplemental Content

Loading ...
Support Center